|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1994; 23:1370-1377 © 1994 by the American College of Cardiology Foundation |
Department of Medicine, University of Oulu, Finland.
OBJECTIVES. This study assessed the effects of beta-blockade on heart rate variability in patients with coronary artery disease and determined whether the effects of metoprolol in a controlled-release formulation and atenolol differ with regard to electrocardiographic measures of cardiac autonomic control. BACKGROUND. Low heart rate variability is common in coronary artery disease and is associated with increased mortality. Beta-adrenergic blocking drugs may increase heart rate variability in healthy subjects, but there is limited knowledge of whether they are able to modify heart rate variability in patients with uncomplicated coronary artery disease. METHODS. In a randomly allocated, double-blind crossover study with three 2-week treatment periods, 200 mg of controlled-release metoprolol once a day, 100 mg of atenolol once a day or placebo once a day were administered in 18 male patients with stable coronary artery disease. The 24-h heart rate variability was measured in both the time and frequency domains. RESULTS. Beta-blockade induced a significant increase in heart rate variability, but no significant differences were found between atenolol and metoprolol. The average 24-h high frequency power increased by 64% after atenolol and by 62% after metoprolol. The root-mean-square successive difference of normal RR intervals increased by 70% after atenolol and by 62% after metoprolol, and the standard deviations of RR intervals increased by 20% and 16%, respectively. Beta-blockade had no significant effects on the amplitude of the circadian rhythm of heart rate variability, although both metoprolol and atenolol blunted the abrupt decrease of high frequency power after arousal. CONCLUSIONS. Beta-blockade by metoprolol and atenolol enhance the heart rate variability in patients with coronary artery disease. This may contribute to the protective effects of beta-blockade in ischemic heart disease.
This article has been cited by other articles:
|
|
 |
|
  J. J. Bailey, M. Hodges, and T. R. Church Decision to Implant a Cardioverter Defibrillator after Myocardial Infarction: The Role of Ejection Fraction v. Other Risk Factor Markers Med Decis Making, March 1, 2007; 27(2): 151 - 160. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Roach, W. Wilson, D. Ritchie, and R. Sheldon Dissection of long-range heart rate variability: Controlled induction of prognostic measures by activity in the laboratory J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2271 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. V. Huikuri, J. M. Tapanainen, K. Lindgren, P. Raatikainen, T. H. Makikallio, K. E. Juhani Airaksinen, and R. J. Myerburg Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era J. Am. Coll. Cardiol., August 20, 2003; 42(4): 652 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Forslund, I Bjorkander, M Ericson, C Held, T Kahan, N Rehnqvist, and P Hjemdahl Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris Heart, May 1, 2002; 87(5): 415 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mortara, M. T. La Rovere, G. D. Pinna, R. Maestri, S. Capomolla, and F. Cobelli Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1612 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Carney, K. E. Freedland, P. K. Stein, J. A. Skala, P. Hoffman, and A. S. Jaffe Change in Heart Rate and Heart Rate Variability During Treatment for Depression in Patients With Coronary Heart Disease Psychosom Med, September 1, 2000; 62(5): 639 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pruvot, G. Thonet, J.-M. Vesin, G. van-Melle, K. Seidl, H. Schmidinger, J. Brachmann, W. Jung, E. Hoffmann, R. Tavernier, et al. Heart Rate Dynamics at the Onset of Ventricular Tachyarrhythmias as Retrieved From Implantable Cardioverter-Defibrillators in Patients With Coronary Artery Disease Circulation, May 23, 2000; 101(20): 2398 - 2404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Licker, A. Schweizer, L. Hohn, C. Farinelli, and D. R. Morel Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors Can J Anesth, May 1, 2000; 47(5): 433 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Carney, K. E. Freedland, R. C. Veith, and A. S. Jaffe Can Treating Depression Reduce Mortality After an Acute Myocardial Infarction? Psychosom Med, September 1, 1999; 61(5): 666 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Weber, H. Schneider, T. von Arnim, and W. Urbaszek Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris: Influence of drug therapy and prognostic value Eur. Heart J., January 1, 1999; 20(1): 38 - 50. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Taylor, D. L. Carr, C. W. Myers, and D. L. Eckberg Mechanisms Underlying Very-Low-Frequency RR-Interval Oscillations in Humans Circulation, August 11, 1998; 98(6): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Kardos, V Long, J Bryant, J Singh, P Sleight, and B Casadei Lipophilic versus hydrophilic beta 1 blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction Heart, February 1, 1998; 79(2): 153 - 160. [Abstract] [Full Text]
|
|
|
|
|
|
N. Singh, D. Mironov, P. W. Armstrong, A. M. Ross, and A. Langer Heart Rate Variability Assessment Early After Acute Myocardial Infarction : Pathophysiological and Prognostic Correlates Circulation, April 1, 1996; 93(7): 1388 - 1395. [Abstract] [Full Text]
|
|
|
|
|
|
Y. S. Tuininga, H. J.G.M. Crijns, J. Brouwer, M. P. van den Berg, A. J. Man in't Veld, G. Mulder, and K.I. Lie Evaluation of Importance of Central Effects of Atenolol and Metoprolol Measured by Heart Rate Variability During Mental Performance Tasks, Physical Exercise, and Daily Life in Stable Postinfarct Patients Circulation, December 15, 1995; 92(12): 3415 - 3423. [Abstract] [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
